Inhibitors of mammalian G1 cyclin-dependent kinases. | Synapse
May 15, 1995Open Access
Inhibitors of mammalian G1 cyclin-dependent kinases.
Key Points
The study focuses on understanding the mechanisms and effects of inhibitors targeting G1 cyclin-dependent kinases in mammalian cells.
Analysis of G1 cyclin-dependent kinase inhibition mechanisms
Investigation of physiological impacts on cell cycle progression
Evaluation of potential therapeutic implications in tumor biology
Inhibition of G1 cyclin-dependent kinases significantly reduces cell proliferation in mammalian cell lines.
The study identifies several novel inhibitors that effectively block G1 kinase activity, leading to cell cycle arrest.
Abstract
C J Sherr and J M Roberts Howard Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38104, USA.